Scientists have achieved breakthrough by developing a pill that can cure diabetes by simply "rewiring" the body.
The new study suggests that a "probiotic pill" which contains live bacteria found in the human gut, could radically reduce blood glucose levels from the pancreas to the upper intestine, the Daily Express reported.
It is believed that this "rewiring" of the body could revolutionise treatment for diabetes - both Types 1 and 2 - and potentially one day offer the possibility of a cure. Lead researcher Professor John March said that if it worked, all people would have to do was to take the pill to control their diabetes.
Professor March said that probiotics are generally regarded as safe by the Food and Drug Administration, and were already available, people already took them, and they haven't had any adverse side effects.
The scientists are now prepping to take the exciting new discovery to the next stage by testing higher doses of the engineered probiotic in diabetic rats, and if successful, it could then be made into a pill for human use.
The study is published in the journal Diabetes.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
